UBS Group’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.1K | Sell |
5,073
-23,478
| -82% | -$79.1K | ﹤0.01% | 7233 |
|
|
2025
Q1 | $43.4K | Sell |
28,551
-23,942
| -46% | -$36.4K | ﹤0.01% | 6399 |
|
|
2024
Q4 | $115K | Buy |
52,493
+20,948
| +66% | +$46.1K | ﹤0.01% | 5568 |
|
|
2024
Q3 | $78.5K | Buy |
31,545
+24,492
| +347% | +$61K | ﹤0.01% | 5337 |
|
|
2024
Q2 | $9.03K | Sell |
7,053
-21,898
| -76% | -$28K | ﹤0.01% | 6608 |
|
|
2024
Q1 | $83.7K | Buy |
+28,951
| New | +$83.7K | ﹤0.01% | 5144 |
|
|
2023
Q2 | – | Sell |
-2,713
| Closed | -$26.3K | – | 8080 |
|
|
2023
Q1 | $26.3K | Buy |
+2,713
| New | +$26.3K | ﹤0.01% | 5791 |
|
|
2022
Q4 | – | Sell |
-105
| Closed | -$2K | – | 9648 |
|
|
2022
Q3 | $2K | Sell |
105
-1,296
| -93% | -$24.7K | ﹤0.01% | 8625 |
|
|
2022
Q2 | $8K | Sell |
1,401
-1,862
| -57% | -$10.6K | ﹤0.01% | 7271 |
|
|
2022
Q1 | $21K | Buy |
3,263
+1,643
| +101% | +$10.6K | ﹤0.01% | 6351 |
|
|
2021
Q4 | $26K | Buy |
1,620
+501
| +45% | +$8.04K | ﹤0.01% | 6425 |
|
|
2021
Q3 | $30K | Buy |
+1,119
| New | +$30K | ﹤0.01% | 5627 |
|